Abstract

Purpose : To improve the oral bioavailability of berberine using a new self-nanoemulsifying drug delivery system (SNEDDS). Methods : Berberine SNEDDS was designed using solubility studies and phase diagram construction. A series of tests were carried out to study the effect of oil content, dilution, and drug loading on particle size. The morphology of the nanoemulsion was examined with a transmission electron microscope. Subsequently, the optimized berberine SNEDDS was investigated for in vitro release and compared with two marketed products (Xiaowei capsules and Beike tablets) Results : The optimized formulation, composed of berberine of 6.0 %, castor oil of 18.8 %, Tween 20 of 37.6 %, and glycerol of 37.6 %, gave a mean particle size of approximately 60 nm, and was not affected by dilution. The optimized formulation released 90 % berberine in 20 min, while the reference products, Xiaowei capsules and Beike tablets, required 2 h to release 90 % of berberine. Conclusion : The optimized formulation of SNEDDS is a potential alternative oral dosage form for improving oral absorption of berberine. Keywords : Berberine, Pseudoternary phase diagram, Self-nanoemulsifying, SNEDDS, Drug release

Highlights

  • Self-nanoemulsifying drug delivery systems (SNEDDS) are isotropic and thermodynamically stable solutions consisting of oil, surfactant, cosurfactant and drug that can self-emulsify quickly in the stomach aqueous contents

  • SNEDDS were diluted with aqueous medium (1:50) and centrifuged at 4,000 rpm for 30 min and formulation were observed visually for phase separation and drug precipitation

  • Enhancement of bioavailability of berberine SNEDDS compared with Beike tablets and Xiaowei capsules may be due to effects of the large quantities of surfactant and cosurfactant used which include improved mucosal permeability, smaller lipid droplets and greater surface area

Read more

Summary

Introduction

Self-nanoemulsifying drug delivery systems (SNEDDS) are isotropic and thermodynamically stable solutions consisting of oil, surfactant, cosurfactant and drug that can self-emulsify quickly in the stomach aqueous contents. It introduces the drug in solution within nanosized oil droplets [1,2,3]. Berberine is one of the major components of Coptis chinensis Franch. It has been clinically applied for decades because of its significant effect. The current commercially marketed dosage forms are tablets and capsules Both of these exhibit low and erratic oral bioavailability, which is mainly due to the poor dissolution of the drug

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.